Shaojun Peng Selected Research

Shaojun Peng Research Topics

Disease

20	Neoplasms (Cancer) 05/2024 - 07/2018
6	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2022
3	Glioma (Gliomas) 05/2024 - 05/2021
3	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2022
3	Hypoxia (Hypoxemia) 01/2024 - 02/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 01/2022
2	Liver Neoplasms (Liver Cancer) 01/2024 - 02/2021
2	Inflammation (Inflammations) 06/2023 - 04/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024
1	Bacterial Infections (Bacterial Infection) 07/2023
1	Wounds and Injuries (Trauma) 07/2023
1	Starvation 07/2023
1	Bites and Stings (Sting) 01/2022
1	Hemorrhagic Shock 10/2019
1	Carcinoma (Carcinomatosis) 07/2018
1	Carcinogenesis 03/2017

Drug/Important Bio-Agent (IBA)

5	PolymersIBA 05/2024 - 03/2019
4	NanogelsIBA 05/2024 - 07/2018
3	EnzymesIBA 03/2024 - 01/2022
3	Phosphorylcholine (Phosphocholine)IBA 02/2021 - 03/2019
2	NanovaccinesIBA 05/2024 - 01/2024
2	InterferonsIBA 05/2024 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024 - 01/2022
2	ProdrugsIBA 01/2024 - 12/2021
2	Glucose (Dextrose)FDA LinkGeneric 07/2023 - 11/2021
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2021 - 11/2021
2	Sulfur DioxideIBA 12/2021 - 01/2020
2	polyethylene glycol polyethyleneimine nanogelIBA 02/2021 - 07/2018
2	Metal-Organic FrameworksIBA 01/2020 - 10/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024
1	Imiquimod (Aldara)FDA LinkGeneric 05/2024
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2024
1	poly-N-vinylcaprolactamIBA 05/2024
1	dermorphinIBA 05/2024
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2024
1	GossypolIBA 04/2024
1	Excipients (Suspending Agents)IBA 01/2024
1	resiquimodIBA 01/2024
1	Tirapazamine (SR 4233)IBA 01/2024
1	Complement System Proteins (Complement)IBA 12/2023
1	Therapeutic UsesIBA 12/2023
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 07/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2023
1	Glucose OxidaseIBA 07/2023
1	Hyaluronic Acid (Hyaluronan)IBA 06/2023
1	CurcuminIBA 06/2023
1	3-(2'-pyridyldithio)benzyldiazoacetate (MPDA)IBA 06/2023
1	HydrogelsIBA 06/2023
1	ChitosanIBA 06/2023
1	CyclodextrinsIBA 06/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022
1	Bromelains (Bromelain)IBA 01/2022
1	Liposomes (Liposome)IBA 01/2022
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	ferrous sulfideIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 12/2021
1	HydrogenIBA 12/2021
1	Carbon MonoxideIBA 12/2021
1	AcidsIBA 11/2021
1	Glutathione (Reduced Glutathione)IBA 11/2021
1	Biocompatible Materials (Biomaterials)IBA 08/2021
1	Contrast MediaIBA 05/2021
1	Cidofovir (Vistide)FDA Link 02/2021
1	MicellesIBA 02/2021
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	hemoglobin ASIBA 10/2019
1	Oxygen (Dioxygen)IBA 10/2019
1	sulfobetaine methacrylate polymerIBA 07/2018
1	ArsenicIBA 03/2017
1	Silicon Dioxide (Silica)FDA LinkGeneric 04/2016

Therapy/Procedure

14	Therapeutics 05/2024 - 01/2020
6	Immunotherapy 05/2024 - 01/2022
5	Drug Therapy (Chemotherapy) 04/2024 - 01/2020
3	Photothermal Therapy 06/2023 - 01/2020
2	Precision Medicine 05/2024 - 04/2024
2	Lasers (Laser) 11/2022 - 03/2019
2	Radiotherapy 01/2022 - 12/2021
1	Injections 06/2023
1	Aftercare (After-Treatment) 01/2022
1	Photochemotherapy (Photodynamic Therapy) 12/2021
1	Intravenous Injections 07/2018